Praxis Precision Medicines Inc
Research Praxis Precision Medicines Inc (PRAX) on Bullrun: market cap USD 9.77B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPRAX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 9.77B
- Financial periodFY2025
- Revenue growth-100.0%
- Net income-USD 303.00M
- Free cash flow-USD 249.12M
Valuation Snapshot
latest market cap is USD 9.77B.
About Praxis Precision Medicines Inc
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States. The company's platforms include Cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and Solidus to discover and develop antisense oligonucleotide.
Frequently asked questions
What is Praxis Precision Medicines Inc's market cap?
Praxis Precision Medicines Inc's market capitalization is USD 9.77B.
What does Praxis Precision Medicines Inc do?
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.